May 2, 2016
Theravance Biopharma to Report First Quarter 2016 Financial Results on May 9, 2016
April 28, 2016
Theravance Biopharma Announces Pricing of Public Offering of Its Ordinary Shares
April 27, 2016
Theravance Biopharma Announces Proposed Public Offering of Its Ordinary Shares
Medicines that make a difference®
We apply our multivalency expertise to discover, develop and commercialize small molecule medicines for significant unmet medical needs.
We pursue a best-in-class strategy designed to discover superior medicines across multiple therapeutic areas.
In some instances, we partner our programs in order to accelerate timelines and better align resources.
Every day at Theravance Biopharma, we think it through, find a way, and get it done so that together with our partners we can bring patients much needed new medicines.
Theravance Biopharma discovers, develops and brings important medicines to patients by: